During the past decade, Suining Central Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Suining Central Hospital" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Shanghai Henlius Biotech" with 1 trials sponsored, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials sponsored, "Sichuan Academy of Medical Sciences" with 1 trials sponsored and "Sichuan Cancer Hospital and Research Institute" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Suining Central Hospital" #1 collaborator was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials as a collaborator and "Sichuan Provincial People's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Suining Central Hospital" are "Abnormal Mucus Secretions" (1 trials), "Acute Ischemic Stroke" (1 trials), "Alteplase" (1 trials), "Basilar Artery Occlusion" (1 trials) and "Endovascular Treatment" (1 trials). Many other conditions were trialed in "Suining Central Hospital" in a lesser frequency.

Most popular intervention types in "Suining Central Hospital" are "Drug" (5 trials), "Biological" (2 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ambroxol hydrochloride 30 mg" (1 trials), "Atezolizumab" (1 trials), "Atezolizumab Matching Placebo" (1 trials), "Cisplatin" (1 trials) and "Echocardiography" (1 trials). Other intervention names were less common.

The vast majority of trials in "Suining Central Hospital" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Suining Central Hospital". 1 are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Suining Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Suining Central Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".